Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Miconazole is the active ingredient of these drugs:
Cyprus Hong Kong Singapore
Germany
Brazil
Brazil
Hong Kong
Australia Austria Brazil Cyprus Finland
Brazil
Hong Kong Singapore
Hong Kong
Spain
Singapore
Brazil
Brazil
Cyprus Finland Ireland Netherlands United Kingdom
Poland
Hong Kong
Germany
France
Canada
Brazil
Brazil
Brazil
Tunisia
Germany
Brazil
Canada
Hong Kong
Singapore
Brazil
Canada
Singapore
Hong Kong
Tunisia
Hong Kong
United States
Hong Kong
Hong Kong Singapore
Brazil
Brazil
Hong Kong Singapore
Miconazole is also found within below combination drugs:
ACCURE , ACNE PLUS , AMPLIUM G , BOSTON , BRENTAN , CANDIPLAS H , CARIDERMA , CLOTASODINE , CLOTASONE , CO-BETA-N , CREVAGIN , DAFRIN-H , DAKTACORT , DECOCORT , DERMIC , DERMOVAGIN , ELLAWON , EUGENCORT , FLURADERM , FUBETA , FUHARKIN , FUNGA-F , FUOCORTE-F , GINO-COLON , GYNOTRAN , HAVANDA , HYDRO-FUNGA , KENDERM , KENNETIC , KENOVAN , KLION-D , LONGAXON , MICOSONE , MINAZOLE , MONICURE COMBO , MYCOSOLON , POTADERM-FORTE , PROHEALAN , RESOLVE PLUS , SIROLIN , TAIRO , TARA-PLUS , TETCOM , TINACORT , TOLNAZOLE , TRI-MICON , TRINIZOL-M , VOBADERM , VODADERM , VUSION , XATIM , ZARICORT
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):